线粒体在脑出血后铁死亡中的调控机制和靶向治疗研究新进展

doi:10.12114/j.issn.1007-9572.2024.0645

中国全科医学 ›› 2026, Vol. 29 ›› Issue (32): 4827-4832.DOI: 10.12114/j.issn.1007-9572.2024.0645

• 综述与专论 • 上一篇

线粒体在脑出血后铁死亡中的调控机制和靶向治疗研究新进展

赵麒羽¹^,², 李欣悦¹^,³, 吴民民¹^,³, 陈秋欣¹^,²^,^*()

1．150040　黑龙江省哈尔滨市，黑龙江中医药大学
2．150040　黑龙江省哈尔滨市，黑龙江中医药大学附属第一医院
3．150040　黑龙江省哈尔滨市，黑龙江中医药大学附属第二医院

收稿日期:2025-04-10 修回日期:2025-05-30 出版日期:2026-11-15 发布日期:2026-10-10
通讯作者: 陈秋欣
作者贡献：
赵麒羽负责文章的构思与设计、研究资料的收集与整理、论文撰写；李欣悦、吴民民负责论文修订、文章的质量控制；陈秋欣负责对文章审校、对文章整体负责，监督管理。
基金资助:
国家自然科学基金青年科学基金项目(82004442); 黑龙江省自然科学基金联合引导项目(LH2022H081)

Regulatory Mechanisms and Targeted Therapeutic Research of Mitochondria in Ferroptosis Following Cerebral Hemorrhage

ZHAO Qiyu¹^,², LI Xinyue¹^,³, WU Minmin¹^,³, CHEN Qiuxin¹^,²^,^*()

1. Heilongjiang University of Chinese Medicine, Harbin 150040, China
2. The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040, China
3. The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040, China

Received:2025-04-10 Revised:2025-05-30 Published:2026-11-15 Online:2026-10-10
Contact: CHEN Qiuxin

摘要/Abstract

摘要： 脑出血（ICH）是一种高死亡率和致残率的脑卒中类型，铁死亡在ICH后的继发性损伤中扮演重要角色。线粒体作为细胞代谢和能量产生的中心，在铁死亡中具有重要作用，探索线粒体在铁死亡中的作用对治疗ICH后继发性损伤具有重要意义。本文结合ICH后铁死亡过程，从线粒体活性氧（ROS）和线粒体渗透性转换孔（mPTP）、线粒体三羟酸循环（TCA）、线粒体自噬、线粒体脱氧核糖核酸（mtDNA）、线粒体二氢乳清酸脱氢酶（DHODH）等方面探讨其在铁死亡中的作用，并结合靶向线粒体治疗铁死亡的研究进展，为ICH后继发性损伤的干预提供新思路。

关键词: 脑出血, 线粒体, 铁死亡, 活性氧, 线粒体自噬, 二氢乳清酸脱氢酶

Abstract:

Intracerebral hemorrhage (ICH) is a type of stroke with high mortality and disability rates. Ferroptosis plays a significant role in the secondary injury following ICH. Mitochondria, as the center of cellular metabolism and energy production, has an important role in ferroptosis. Exploring the role of mitochondria in ferroptosis is of great significance for the treatment of secondary injuries after ICH. This article discuss the role of mitochondria in ferroptosis from various aspects, including mitochondrial reactive oxygen species (ROS) and mitochondrial permeability transition pore (mPTP), mitochondrial tricarboxylic acid (TCA) cycle, mitochondrial autophagy, mitochondrial DNA (mtDNA), and mitochondrial dihydroorotate dehydrogenase (DHODH), in the context of ferroptosis following ICH. It also reviews the latest research on targeting mitochondria for the treatment of ferroptosis, providing new insights for the intervention of secondary injuries after ICH.

Key words: Intracerebral hemorrhage, Mitochondria, Ferroptosis, Reactive oxygen species, Mitophagy, Dihydroorotate dehydrogenase

中图分类号:

R 743.3

赵麒羽,李欣悦,吴民民,等. 线粒体在脑出血后铁死亡中的调控机制和靶向治疗研究新进展[J]. 中国全科医学, 2026, 29(32): 4827-4832. DOI: 10.12114/j.issn.1007-9572.2024.0645.
ZHAO Qiyu,LI Xinyue,WU Minmin, et al. Regulatory Mechanisms and Targeted Therapeutic Research of Mitochondria in Ferroptosis Following Cerebral Hemorrhage[J]. Chinese General Practice, 2026, 29(32): 4827-4832. DOI: 10.12114/j.issn.1007-9572.2024.0645.

参考文献 53

[1]	Donkor E S. Stroke in the 21st century: a snapshot of the burden, epidemiology, and quality of life[J]. Stroke Res Treat, 2018, 2018: 3238165. DOI: 10.1155/2018/3238165.
[2]	An S J, Kim T J, Yoon B W. Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update[J]. J Stroke, 2017, 19(1): 3-10. DOI: 10.5853/jos.2016.00864.
[3]	Andrew Wilkinson D, Keep R F, Hua Y, et al. Hematoma clearance as a therapeutic target in intracerebral hemorrhage: from macro to micro[J]. J Cereb Blood Flow Metab, 2018, 38(4): 741-745.
[4]	Alsbrook D L, Di Napoli M, Bhatia K, et al. Neuroinflammation in acute ischemic and hemorrhagic stroke[J]. Curr Neurol Neurosci Rep, 2023, 23(8): 407-431.
[5]	Wang J. Preclinical and clinical research on inflammation after intracerebral hemorrhage[J]. Prog Neurobiol, 2010, 92(4): 463-477.
[6]	Glover H L, Schreiner A, Dewson G, et al. Mitochondria and cell death[J]. Nat Cell Biol, 2024, 26(9): 1434-1446.
[7]	Dixon S J, Lemberg K M, Lamprecht M R, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149(5): 1060-1072. DOI: 10.1016/j.cell.2012.03.042.
[8]	Hirschhorn T, Stockwell B R. The development of the concept of ferroptosis[J]. Free Radic Biol Med, 2019, 133: 130-143.
[9]	Galaris D, Barbouti A, Pantopoulos K. Iron homeostasis and oxidative stress: an intimate relationship[J]. Biochim Biophys Acta Mol Cell Res, 2019, 1866(12): 118535.
[10]	Yoshinaga M, Nakatsuka Y, Vandenbon A, et al. Regnase-1 maintains iron homeostasis via the degradation of transferrin receptor 1 and prolyl-hydroxylase-domain-containing protein 3 mRNAs[J]. Cell Rep, 2017, 19(8): 1614-1630.
[11]	Cao S L, Hua Y, Keep R F, et al. Minocycline effects on intracerebral hemorrhage-induced iron overload in aged rats: brain iron quantification with magnetic resonance imaging[J]. Stroke, 2018, 49(4): 995-1002.
[12]	Sun Y Y, Li Q, Guo H X, et al. Ferroptosis and iron metabolism after intracerebral hemorrhage[J]. Cells, 2022, 12(1): 90.
[13]	Chen J H, Wang Y H, Wu J Y, et al. The potential value of targeting ferroptosis in early brain injury after acute CNS disease[J]. Front Mol Neurosci, 2020, 13: 110.
[14]	Nunnari J, Suomalainen A. Mitochondria: in sickness and in health[J]. Cell, 2012, 148(6): 1145-1159.
[15]	Wiernicki B, Dubois H, Tyurina Y Y, et al. Excessive phospholipid peroxidation distinguishes ferroptosis from other cell death modes including pyroptosis[J]. Cell Death Dis, 2020, 11(10): 922.
[16]	Jelinek A, Heyder L, Daude M, et al. Mitochondrial rescue prevents glutathione peroxidase-dependent ferroptosis[J]. Free Radic Biol Med, 2018, 117: 45-57.
[17]	Murphy M P. How mitochondria produce reactive oxygen species[J]. Biochem J, 2009, 417(1): 1-13.
[18]	Cong J, Li J Y, Zou W. Mechanism and treatment of intracerebral hemorrhage focus on mitochondrial permeability transition pore[J]. Front Mol Neurosci, 2024, 17: 1423132.
[19]	Baines C P, Kaiser R A, Purcell N H, et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death[J]. Nature, 2005, 434(7033): 658-662.
[20]	Lam C K, Zhao W, Liu G S, et al. HAX-1 regulates cyclophilin-D levels and mitochondria permeability transition pore in the heart[J]. Proc Natl Acad Sci USA, 2015, 112(47): E6466-E6475.
[21]	Ganguly U, Singh S, Bir A, et al. Alpha-synuclein interaction with mitochondria is the final mechanism of ferroptotic death induced by erastin in SH-SY5Y cells[J]. Free Radic Res, 2024, 58(3): 217-228.
[22]	Hurst S, Hoek J, Sheu S S. Mitochondrial Ca²⁺ and regulation of the permeability transition pore[J]. J Bioenerg Biomembr, 2017, 49(1): 27-47. DOI: 10.1007/s10863-016-9672-x.
[23]	Liu E Y, Sun H D, Wu J P, et al. miR-92b-3p regulates oxygen and glucose deprivation-reperfusion-mediated apoptosis and inflammation by targeting TRAF3 in PC12 cells[J]. Exp Physiol, 2020, 105(10): 1792-1801. DOI: 10.1113/EP088708.
[24]	Basit F, Van Oppen L M, Schöckel L, et al. Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells[J]. Cell Death Dis, 2017, 8(3): e2716. DOI: 10.1038/cddis.2017.133.
[25]	Gao M H, Yi J M, Zhu J J, et al. Role of mitochondria in ferroptosis[J]. Mol Cell, 2019, 73(2): 354-363.e3.
[26]	Guan R Q, Zou W, Dai X H, et al. Mitophagy, a potential therapeutic target for stroke[J]. J Biomed Sci, 2018, 25(1): 87.
[27]	Zhu Y L, Zhang J N, Deng Q J, et al. Mitophagy-associated programmed neuronal death and neuroinflammation[J]. Front Immunol, 2024, 15: 1460286.
[28]	Wang S L, Long H J, Hou L J, et al. The mitophagy pathway and its implications in human diseases[J]. Signal Transduct Target Ther, 2023, 8(1): 304.
[29]	Tan X, Yang Y, Xu J G, et al. Luteolin exerts neuroprotection via modulation of the p62/Keap1/Nrf2 pathway in intracerebral hemorrhage[J]. Front Pharmacol, 2020, 10: 1551.
[30]	Cheng Y J, Liu M J, Tang H, et al. iTRAQ-based quantitative proteomics indicated Nrf2/OPTN-mediated mitophagy inhibits NLRP3 inflammasome activation after intracerebral hemorrhage[J]. Oxid Med Cell Longev, 2021, 2021: 6630281.
[31]	Yamashita S I, Sugiura Y, Matsuoka Y, et al. Mitophagy mediated by BNIP3 and NIX protects against ferroptosis by downregulating mitochondrial reactive oxygen species[J]. Cell Death Differ, 2024, 31(5): 651-661. DOI: 10.1038/s41418-024-01280-y.
[32]	Wang X D, Ma H D, Sun J, et al. Mitochondrial ferritin deficiency promotes osteoblastic ferroptosis via mitophagy in type 2 diabetic osteoporosis[J]. Biol Trace Elem Res, 2022, 200(1): 298-307.
[33]	Wang Y, Wang R F, Zhu J Z, et al. Identification of mitophagy and ferroptosis-related hub genes associated with intracerebral haemorrhage through bioinformatics analysis[J]. Ann Hum Biol, 2024, 51(1): 2334719. DOI: 10.1080/03014460.2024.2334719.
[34]	Yan C J, Duanmu X Y, Zeng L, et al. Mitochondrial DNA: distribution, mutations, and elimination[J]. Cells, 2019, 8(4): 379.
[35]	Alam T I, Kanki T, Muta T, et al. Human mitochondrial DNA is packaged with TFAM[J]. Nucleic Acids Res, 2003, 31(6): 1640-1645. DOI: 10.1093/nar/gkg251.
[36]	Guo J Y, Duan L F, He X Y, et al. A combined model of human iPSC-derived liver organoids and hepatocytes reveals ferroptosis in DGUOK mutant mtDNA depletion syndrome[J]. Adv Sci, 2021, 8(10): 2004680. DOI: 10.1002/advs.202004680.
[37]	Zhong S F, Chen W J, Wang B C, et al. Energy stress modulation of AMPK/FoxO3 signaling inhibits mitochondria-associated ferroptosis[J]. Redox Biol, 2023, 63: 102760.
[38]	Wu Y N, Song J, Wang Y F, et al. The potential role of ferroptosis in neonatal brain injury[J]. Front Neurosci, 2019, 13: 115.
[39]	Gu F, Wang Z Q, Ding H J, et al. Microglial mitochondrial DNA release contributes to neuroinflammation after intracerebral hemorrhage through activating AIM2 inflammasome[J]. Exp Neurol, 2024, 382: 114950. DOI: 10.1016/j.expneurol.2024.114950.
[40]	Mishima E, Nakamura T, Zheng J S, et al. DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition[J]. Nature, 2023, 619(7968): E9-E18. DOI: 10.1038/s41586-023-06269-0.
[41]	Mao C, Liu X G, Zhang Y L, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer[J]. Nature, 2021, 593(7860): 586-590.
[42]	Zhang J T, Zhu Q, Peng Z, et al. Menaquinone-4 attenuates ferroptosis by upregulating DHODH through activation of SIRT1 after subarachnoid hemorrhage[J]. Free Radic Biol Med, 2024, 210: 416-429. DOI: 10.1016/j.freeradbiomed.2023.11.031.
[43]	Li X N, Lin L, Li X W, et al. BSA-stabilized selenium nanoparticles ameliorate intracerebral hemorrhage's-like pathology by inhibiting ferroptosis-mediated neurotoxicology via Nrf2/GPX4 axis activation[J]. Redox Biol, 2024, 75: 103268.
[44]	Li J, Jia Y C, Ding Y X, et al. The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks[J]. Int J Biol Sci, 2023, 19(9): 2756-2771. DOI: 10.7150/ijbs.83348.
[45]	Sr X L, Liu W, Jiang G N, et al. Celastrol ameliorates neuronal mitochondrial dysfunction induced by intracerebral hemorrhage via targeting cAMP-activated exchange protein-1[J]. Adv Sci, 2024, 11(19): e2307556. DOI: 10.1002/advs.202307556.
[46]	高莹，杨建. 针刺干预脑出血的铁死亡应激机制[J]. 辽宁中医杂志, 2024, 51(8): 190-193, 226.
[47]	Li D, Wang L, Shi S F, et al. Ubiquitin-like 4A alleviates the progression of intracerebral hemorrhage by regulating oxidative stress and mitochondrial damage[J]. Exp Anim, 2024, 73(4): 421-432.
[48]	Yuan Y, Yang X, Zhao Y, et al. Mitochondrial ferritin upregulation by deferiprone reduced neuronal ferroptosis and improved neurological deficits via NDRG1/Yap pathway in a neonatal rat model of germinal matrix hemorrhage[J]. J Cereb Blood Flow Metab, 2025, 45(3): 510-527. DOI: 10.1177/0271678x241252110.
[49]	Gao G F, Chang Y Z. Mitochondrial ferritin in the regulation of brain iron homeostasis and neurodegenerative diseases[J]. Front Pharmacol, 2014, 5: 19. DOI: 10.3389/fphar.2014.00019.
[50]	Chen W X, Guo C, Huang S N, et al. MitoQ attenuates brain damage by polarizing microglia towards the M2 phenotype through inhibition of the NLRP3 inflammasome after ICH[J]. Pharmacol Res, 2020, 161: 105122. DOI: 10.1016/j.phrs.2020.105122.
[51]	Zhou Y N, Zhang Y, Xu D C, et al. Exosomes from polarized Microglia: Proteomic insights into potential mechanisms affecting intracerebral hemorrhage[J]. Gene, 2025, 935: 149080.
[52]	Wang R K, Liang Z, Xue X Y, et al. Microglial FoxO3a deficiency ameliorates ferroptosis-induced brain injury of intracerebral haemorrhage via regulating autophagy and heme oxygenase-1[J]. J Cell Mol Med, 2024, 28(1): e18007. DOI: 10.1111/jcmm.18007.
[53]	Marmolejo-Garza A, Krabbendam I E, Luu M D A, et al. Negative modulation of mitochondrial calcium uniporter complex protects neurons against ferroptosis[J]. Cell Death Dis, 2023, 14(11): 772. DOI: 10.1038/s41419-023-06290-1.

线粒体在脑出血后铁死亡中的调控机制和靶向治疗研究新进展

Regulatory Mechanisms and Targeted Therapeutic Research of Mitochondria in Ferroptosis Following Cerebral Hemorrhage

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 53

相关文章 15

编辑推荐

Metrics

留言

[1]	阮何静, 赵文, 李龙灿, 赵久法, 李冬冬. 帕金蛋白在代谢相关脂肪性肝病中的潜在非经典功能及治疗展望[J]. 中国全科医学, 2026, 29(23): 3268-3274.
[2]	简迎春, 曾永秦, 张海平, 王争地, 安科, 严瑞. 线粒体功能障碍在慢性代谢性疾病中的研究进展[J]. 中国全科医学, 2026, 29(18): 2577-2584.
[3]	吕小娇, 柏子寒, 马妍, 陈巍, 曲扬, 隋国媛, 尚冰, 丛培玮. 二陈汤干预ATG7/FTH1通路改善痰湿型多囊卵巢综合征大鼠卵泡功能的研究[J]. 中国全科医学, 2026, 29(05): 649-655.
[4]	高桂英, 胡阳, 张世益, 孟怡, 邓洁. 运动康复改善冠状动脉微循环障碍的相关机制研究进展[J]. 中国全科医学, 2025, 28(20): 2570-2576.
[5]	朱子一, 何贵新, 秦伟彬, 宋惠, 张利文, 唐伟智, 杨斐斐, 刘凌云, 欧阳彬. 线粒体自噬改善心肌梗死后心肌纤维化及其中医药干预的研究进展[J]. 中国全科医学, 2025, 28(18): 2294-2300.
[6]	徐林慧, 李鹏飞, 吴苗苗, 康丽华, 季敏, 俞莹, 管怀进. 去泛素化修饰在衰老相关疾病中的研究进展[J]. 中国全科医学, 2025, 28(09): 1143-1155.
[7]	张天阳, 徐文秀, 秦昕宇, 邢雪雪, 毕玫荣. 铁死亡在新生儿缺氧缺血性脑损伤中的作用机制研究进展[J]. 中国全科医学, 2025, 28(06): 666-672.
[8]	裴金英, 宋金洲, 马到丰, 罗孝廷, 刘斌, 董晓红, 丛树园. 中药提取物调控铁死亡改善阿尔茨海默病的研究新进展[J]. 中国全科医学, 2025, 28(05): 639-648.
[9]	林鑫荣, 贾蕾, 李丽峰, 黄鸣, 吴忠冰, 李晶. 石见穿诱导铁死亡抑制小鼠食管癌发生发展的研究[J]. 中国全科医学, 2024, 27(30): 3784-3789.
[10]	邓琳, 逯军. RRM2B基因突变致线粒体DNA耗竭综合征：两例不同类型（8A和8B）患儿的临床特点和基因分析[J]. 中国全科医学, 2024, 27(29): 3704-3708.
[11]	苏紫威, 马妍, 周彦彰, 周智梁. 中医药调控线粒体质量控制治疗缺血性卒中的研究进展[J]. 中国全科医学, 2024, 27(24): 3023-3030.
[12]	罗国樑, 张馨丹, 唐太春, 朱焰, 汪淑婷, 陈敏. 基于线粒体功能及能量代谢探讨潘氏细胞与肠道干细胞的交互作用及中医药作用的可能靶点研究进展[J]. 中国全科医学, 2024, 27(23): 2864-2868.
[13]	马艺萍, 袁玉娟, 尼格热·阿力木, 阿卜拉江·艾合麦提, 马清玉, 帕丽达·玉山江, 穆叶赛·尼加提. 急性心肌梗死患者外周血内皮细胞微粒miR-126和线粒体成分及黏附分子表达水平及其临床意义研究[J]. 中国全科医学, 2024, 27(23): 2888-2896.
[14]	曹佳岑, 张宏坤, 赵文, 南月敏, 李冬冬. 血红素氧合酶1调节铁死亡在非酒精性脂肪性肝病中的研究进展[J]. 中国全科医学, 2024, 27(14): 1782-1788.
[15]	杜书琴, 钱立锋, 熊烈, 史汉强, 石彦波. 铁死亡：抑郁症治疗的新靶点[J]. 中国全科医学, 2024, 27(12): 1417-1423.